1. FRI0098 Elevated multi-biomarker disease activity (MBDA) predicts relapses in ra patients in sustained remission tapering tumour necrosis factor inhibitor therapy- results from the randomized controlled retro study. (15th June 2017) Authors: Rech, J; Hagen, M; Englbrecht, M; Haschka, J; Reiser, M; Kleyer, A; Hueber, A; Manger, B; Figuereido, C; Cobra, J Fogagnolo; Tony, H-P; Finzel, S; Kleinert, S; Wendler, J; Schuch, F; Ronneberger, M; Feuchtenberger, M; Fleck, M; Manger, K; Ochs, W Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OP0249 Multi-biomarker disease activity and autoantibody status lead to cost effective tapering algorithms in rheumatoid arthritis patients in sustained remission. (15th June 2017) Authors: Hagen, M; Englbrecht, M; Haschka, J; Reiser, M; Kleyer, A; Hueber, A; Manger, B; Figuereido, C; Cobra, J Fogagnolo; Tony, H-P; Finzel, S; Kleinert, S; Wendler, J; Schuch, F; Ronneberger, M; Feuchtenberger, M; Fleck, M; Manger, K; Ochs, W; Schmitt-Haendle, M Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. THU0096 Multi-biomarker disease activity (MBDA) is associated with the progression of structural bone damage in rheumatoid arthritis patients in remission. (15th June 2017) Authors: Schett, G; Finzel, S; Hagen, M; Englbrecht, M; Haschka, J; Figuereido, C; Cobra, J Fogagnolo; Rech, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗